Drug Shortage Report for TIMOPTIC-XE
Report ID | 240755 |
Drug Identification Number | 02171899 |
Brand name | TIMOPTIC-XE |
Common or Proper name | timolol maleate |
Company Name | ELVIUM LIFE SCIENCES |
Market Status | MARKETED |
Active Ingredient(s) | TIMOLOL |
Strength(s) | 0.5% |
Dosage form(s) | SOLUTION (EXTENDED RELEASE) |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 10ml |
ATC code | S01ED |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2024-10-21 |
Actual start date | 2024-10-21 |
Estimated end date | 2025-02-21 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-02-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.